Lixte Biotechnology
LIXT7.2100.00% ( 0.000 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Lixte Biotechnology(LIXT) the EBIT is -1.987 M (-181.1%);the EPS is -0.178 (+37.89%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B181.13%
----
----
EPS
-0.178337.89%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf